Ureaplasma urealyticum medical therapy

Jump to navigation Jump to search

Ureaplasma urealyticum Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ureaplasma urealyticum from other Bacteria

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Ureaplasma urealyticum medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ureaplasma urealyticum medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ureaplasma urealyticum medical therapy

CDC on Ureaplasma urealyticum medical therapy

Ureaplasma urealyticum medical therapy in the news

Blogs on Ureaplasma urealyticum medical therapy

Directions to Hospitals Treating Rhinitis

Risk calculators and risk factors for Ureaplasma urealyticum medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Overview

Antibiotics are the mainstay of treatment for Ureaplasma infection, and antibiotic susceptibility testing is advised prior to treatment due to geographical differences in antibiotic resistance pattern. Doxycycline is recommended as the drug of first choice in non-pregnant women and adults. Josamycin is often recommended for neonates and pregnant women, especially when mixed infection is present. Clarithromycin and pristinamycin are also effective for treating Ureaplasma infection.[1][2][3]

Medical Therapy

Antibiotics are the mainstay of treatment for Ureaplasma infection. Antibiotic susceptibility testing should be done to avoid treatment failure because of the geographical differences in antibiotic resistance.

Recommended antibiotics[1][2][3]

  1. This is the drug of first choice.
  2. It is the most active tetracycline for Mycoplasma and Ureaplasma infection.
  3. It should be avoided in pregnant women and young children.
  1. Josamycin and clarithromycin are the most effective macrolides against Ureaplasma infection.
  2. Josamycin is often recommended for neonates and pregnant women, especially when mixed infection is present.
  3. Pristinamycin can be used as an alternative to Josamycin in pregnant women.
  4. Erythromycin has a low efficacy against Ureaplasma urealyticum.
  • Fluoroquinolones: They have a low efficacy against urogenital Mycoplasma and Ureaplasma infection.
  • Clindamycin: This has also been demonstrated to have a low efficacy against Ureaplasma species.

References

  1. 1.0 1.1 De Francesco MA, Caracciolo S, Bonfanti C, Manca N (2013). "Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years". J Infect Chemother. 19 (4): 621–7. doi:10.1007/s10156-012-0527-z. PMID 23192735.
  2. 2.0 2.1 Resch B, Gutmann C, Reiterer F, Luxner J, Urlesberger B (2016). "Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics". Infection. 44 (3): 323–7. doi:10.1007/s15010-015-0858-7. PMID 26518581.
  3. 3.0 3.1 Lee MY, Kim MH, Lee WI, Kang SY, Jeon YL (2016). "Prevalence and Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in Pregnant Women". Yonsei Med J. 57 (5): 1271–5. doi:10.3349/ymj.2016.57.5.1271. PMC 4960396. PMID 27401661.

Template:WH Template:WS